In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more

EuroCVP 2020

The annual meeting of the ESC Working Group on Cardiovascular Pharmacotherapy

28/05/2020 00:00 29/05/2020 00:00 Europe/Paris EuroCVP 2020

Access event page

ESC Working Group on Cardiovascular Pharmacotherapy true DD/MM/YYYY
Pharmacology and Pharmacotherapy


The course is cancelled.


Dear Members of the Cardiovascular Pharmacotherapy Community,

We regret to inform you that EuroCVP 2020, scheduled for 28-29 May, will not take place as planned.

As the novel coronavirus (COVID–19) has been spreading throughout Europe and beyond, it has prevented many of you from travelling. In addition, the Austrian government has taken preventive measures and prohibited events there until the end of June. Although deeply disappointing, we could not proceed with the courses to be held on site. Your health and safety are of the greatest priority to us.

For the time being, we are maintaining our next courses in October and December this year, and look forward to the next opportunity to meet and network with you all.

Thank you for your understanding and support.

Heinz Drexel, Chairperson of the ESC Working Group on Cardiovascular Pharmacotherapy




This two-day event aims to provide a deep insight into the long journey which brings pharmacological compounds from bench to bedside, i.e. from trial design for testing new drugs (generation and critical appraisal of evidence) to implementation of daily use of pharmacological treatments, of science and patient care.


28 May 2020 (approx. 09h-18h): All About Clinical Trials course

29 May 2020 (approx. 09h-18h): Pharmacotherapy in Older People course

Learning objectives

The specific aim of the All About Clinical Trials course is to improve competency and confidence in:

  • Designing and planning successful clinical trials;
  • Evaluating and following the correct processes and regulatory procedures (GCP certificate included);
  • Effectively analysing and interpreting trial data by highly interactive workshops.

The specific aim of the Pharmacotherapy in Older People course is to improve competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on implementing use of services and pharmacotherapy and thus patient outcomes.

Preliminary programme

Download the preliminary programme.


Registration includes access to both training courses and workshops.

Registration is limited and attributed on a first come, first served basis.

If you have any questions or need any assistance, please contact us on

Registration fees

Category Fee (incl. VAT)
Working Group Members 200€
Working Group Members below 40 140€
Standard fee 450€
PhD medical students Free - on condition*


To apply for a free registration as a PhD medical student, please send an email with your request to

Individual registration

You will be asked to log in to your My ESC account.

Register now

Group registration

To register a group of <5 participants, and for third party registrations, please contact us on

Cancellation policy

Registrations can be refunded according to the following policy:

  • Until 15 May 2020: a cancellation fee of 30% (excl. VAT) applies to the refund
  • After 15 May 2020: no refund is possible

Name changes with justifications can be requested at no expense.


The meeting will be held at:

Medical University of Vienna

Van Swieten Hall

Van-Swieten-Gasse 1a, 1090 Vienna


Who should attend

EuroCVP 2020 is dedicated to an audience of healthcare professionals with clinical/research interest in any field of cardiovascular medicine, e.g. atrial fibrillation, heart failure, hypertension, peripheral vascular and cerebrovascular disease, prevention, general cardiology, coronary artery disease, dyslipidaemia, diabetes. 

  • More specifically, the All About Clinical Trials courses are aimed towards clinical cardiologists and clinical pharmacologists with experience in translational and clinical research in cardiovascular drug therapy. Students or confirmed physicians, who need to improve their knowledge and clinical skills in trial management and interpretation
  • More specifically, the Pharmacotherapy in Older People courses are dedicated to physicians dealing with hospital admissions, ward and outpatient consultations

Feedback from previous courses

All About Clinical Trials

Since its launch in 2015, more than 350 participants have taken this course in clinical trials. 

  • 95% of participants would recommend the course to their peers
  • 65% attend the course to learn about methodology for designing and running a clinical trial
  • 54% attend the course to learn statistical approaches


“The course allowed me not only to gain a deeper insight into the complex process of organising clinical trials, but it also offered an opportunity to discuss specific methodological pitfalls and interpret the results in cooperation with professionals who represent the highest level of expertise in the field. I highly recommend the course both to experienced investigators and to young researchers, since apart from the conventional aspects of clinical trials methodology; it also presented a novel approach to run the research efficiently and successfully.” Aleksandra Gąsecka, Poland

Pharmacotherapy in Older People

The first course on Pharmacotherapy in Older People took place in October 2019 in London, with over 40 participants for the launch.

  • Over 90% of participants found the course extremely useful and useful to their daily practice
  • More than 80% rated the programme as 'excellent', with the speakers and topics as the most cited best aspects of the event
  • 95% of participants declared that the event fulfilled their educational goals and expected learning outcomes